Manifestaciones hepáticas y repercusión en el paciente cirrótico de COVID-19
Resumen: El coronavirus SARS-CoV-2, un nuevo coronavirus, es responsable de la enfermedad infecciosa por coronavirus 19 (COVID-19). A nivel global, esta pandemia va en crecimiento y pudiera afectar al 50-60% de la población mundial en los siguientes meses. Si bien es una enfermedad cuya manifestació...
Main Authors: | J.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, J.M. Remes-Troche |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier
2020-07-01
|
Series: | Revista de Gastroenterología de México |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0375090620300550 |
Similar Items
-
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient
by: J.A. Velarde-Ruiz Velasco, et al.
Published: (2020-07-01) -
The liver in times of COVID-19: What hepatologists should know
by: Ezequiel Ridruejo, et al.
Published: (2020-07-01) -
Management of liver diseases during the pandemic of coronavirus disease-19
by: Ju-Yeon Cho, et al.
Published: (2020-07-01) -
Avaliação da ressecção hepática em pacientes cirróticos com carcinoma hepatocelular Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers
by: Maurício Silva, et al.
Published: (2008-06-01) -
Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease
by: Qian Li, et al.
Published: (2021-05-01)